One of the rate limiting steps in bringing new drugs to market is the time to accrue patients into clinical trials for registration. As the use of social media continues to evolve in the pharmaceutical industry, one area where it may have an impact is to educate patients about clinical research, and share information on trials that are enrolling.
Pieter Droppert on Biotech Strategy Blog looks at the use of social media in cancer treatment. It is estimated that only 3-5% of cancer patients participate in clinical trials.
Using Storify, a new online tool that aggregates information across various social media such as Twitter, Facebook, YouTube, Pieter looks at how social media is being for clinical trial education and recruitment. You can read more on Biotech Strategy Blog.